Bibliografia
Motola D, De Ponti F, Rossi P, et al. Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. Br J Clin Pharmacol 2005; 59: 475–8
International Society of Drug Bulletins. ISDB Declaration on therapeutic advance in the use of medicines. Paris, France: International Society of Drug Bulletins 2001. Disponibile su http://www.icf.uab.es/informacion/boletines/ISDB/ISDB.pdf, accesso del 04/01/2012
Garattini S. Che cosa vuol dire innovatività? Dialogo sui farmaci 2011; n. 3: 95
Frau S, Zimol R. Farmaci innovativi, le criticità della lista dell’AIFA. Dialogo sui farmaci 2011; n. 3: 96–101
Caprino L, Russo P. Developing a paradigm of drug innovation: an evaluation algorithm. Drug Discov Today 2006; 11: 999–1006
Bacchieri A, Della Cioppa G. Fondamenti di ricerca clinica. Milano: Springer-Verlag, 2004
Del Santo F, Maratea D, Messori A. Definizione di farmaco innovativo: rivisitazione in un contesto di risorse limitate. Pharmacoeconomics-Italian Research Articles 2011; 13: 121–4
Hughes DA. Value-based pricing. Incentive for innovation or zero net benefit? Pharmacoeconomics 2011; 29: 731–5
Ferner RE, Hughes DA, Aronson JK. NICE and new: appraising innovation. BMJ 2010; 340: b5493
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Attanasio, E. Dell’innovazione dei farmaci e della determinazione del prezzo basato sul valore. Pharmacoeconomics-Ital-Res-Articles 14, 68–71 (2012). https://doi.org/10.1007/BF03320697
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03320697